We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Articles

Results 1 to 5 of 11
Most popular |Most recent


Lead Compound Analysis is Inappropriate for Method of Treatment Claims

USA - July 5 2019 Addressing the obviousness analysis for method of treatment claims, the US Court of Appeals for the Federal Circu...

Polymorphic patent survives obviousness challenge

USA - April 30 2019 In a Hatch-Waxman case involving patents directed to a polymorphic compound for a treatment for polyneuropathic pain, the US Court of Appeals for the...

Creating Abuse-Resistant Treatments for Opioid Dependence Is Not So Obvious After All

USA - October 24 2018 In a case involving abuse-resistant pharmaceutical compositions for the treatment of opioid dependence, the US Court of Appeals for the Federal...

Missed Connection: Seeking Causal Relationship Between Misconduct and Fee Award

USA - September 26 2018 Addressing an award of attorneys' fees under 35 USC 285, the US Court of Appeals for the Federal Circuit upheld a district court finding that...

Obviousness Cannot Be Predicated on What Is Unknown

USA - August 30 2018 The US Court of Appeals for the Federal Circuit upheld a district court finding that the patent challenger failed to prove that patents directed to a...